JAM2 and colorectal cancer: Kok-Sin et al reported that JAM-B was expressed at very low levels in colorectal cancer due to JAM-B genes being hypermethylated on promoters in CpG islands with methylation-specific multi-plex ligation-dependent probe amplification (MS-MLPA) 14.